- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- N/A
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 409 publications
- Percutaneous Coronary Intervention , 206 publications
- Clopidogrel , 186 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
My publications
Filter publications
822 publications
2024
Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
鈥�2024
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Drugs
2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Journal of the American Heart Association
2024
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.
JAMA cardiology
鈥�2024
P2Y12 Inhibition in Patients Requiring Oral聽Anticoagulation After Percutaneous聽Coronary Intervention: The SWAP-AC-2 Study.
JACC. Cardiovascular interventions
鈥�